hero image
Angela Starkweather, Ph.D. - University of Connecticut. Storrs, CT, US

Angela Starkweather, Ph.D. Angela Starkweather, Ph.D.

Associate Dean, Academic Affairs and Professor, Department of Nursing | University of Connecticut

Storrs, CT, UNITED STATES

Angela Starkweather, PhD, is an expert in symptom science, clinical trials, pain and pain mechanisms.

Biography

Angela Starkweather, Ph.D. is a Professor in the School of Nursing as well as the Director for the P20 Center for Accelerating Precision Pain Self-Management at University of Connecticut.

Areas of Expertise (10)

Omic Measures

Symptom Science

Biobehavioral Research

Cancer

Addiction

Pain Management

Pain

Aging

Stress

Genomics

Education (3)

Loyola University, Chicago: Ph.D. 2005

Loyola University, Chicago: M.S.N. 2000

Seattle Pacific University: B.S.N. 1996

Affiliations (3)

  • Chair, National Institutes of Health Scientific Review Panel, Biobehavioral Mechanisms of Emotion, Stress, and Health
  • Affiliate Professor, Institute for Systems Genomics, University of Connecticut
  • Affiliate Professor, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine

Accomplishments (9)

2019 Audrey Nelson Award (professional)

Academy of Spinal Cord Injury Professionals

2017 Virginia Henderson Award for Excellence in Research (professional)

Connecticut Nursing Association

UConn School of Nursing Difference Maker (professional)

2017

2016 Distinguished Faculty Research Award (professional)

School of Nursing

2015 Outstanding Faculty Mentor Award (professional)

Research Scholars Program

Outstanding Faculty Mentor Award (professional)

Research Scholars Program

Fellow (professional)

American Academy of Nursing

Future of Nursing Leadership Award (professional)

Virginia Nurses Association

Fellow (professional)

American Academy of Nurse Practitioners

Social

Media

Publications:

Documents:

Photos:

loading image loading image

Videos:

Audio:

Research Grants (4)

Self-regulation of yoga for low back pain

National Center for Complementary and Integrative Health $3,000,000

2020 - 2025 The goal of this study is to examine whether emotion regulation is the mechanism of action underlying the health benefits of yoga for improving low back pain and to define the epigenetic signature of pain resolution.

Emotion regulation intervention for preventing collegiate escalations in drinking: a randomized controlled trials to establish acceptability, feasibility and preliminary efficacy

National Institute of Alcohol Abuse and Alcoholism $750,000

2019 - 2022 The goal of this study is to evaluate the acceptability, feasibility and preliminary efficacy of a combined distress tolerance and yoga intervention on alcohol use among college students.

Neurophysiological and transcriptomic predictors of chronic low back pain: Towards precision pain management

NEAT Study $3,000,000

2019 - 2024 The goal of this study is to identify the neurophysiologic and transcriptomic phenotype of the transition from acute to chronic low back pain.

Physiological, psychological, and genomic factors that predict the transition from acute to chronic pain in patients with traumatic lower extremity fracture

Funded by the National Institute of Nursing Research $3,000,000

2018 - 2023 The goals of this study are to elucidate the predictors of chronic pain following traumatic lower extremity fractures.

Articles (5)

Strengthening Inter- And Intraprofessional Collaborations to Advance Biobehavioral Symptom Science Journal of Nursing ScholarshipF

2019 The purpose of this article was to discuss barriers and potential solutions for strengthening inter- and intraprofessional collaborations that will advance biobehavioral symptom science.

view more

Decreasing Risk Among HIV Patients on Opioid Therapy for Chronic Pain: Development of the TOWER Intervention for HIV Care Providers Contemporary Clinical Trials CommunicationsF

2019 Many people with HIV (PWH) experience chronic pain that limits daily function and quality of life. PWH with chronic pain have commonly been prescribed opioids, sometimes for many years, and it is unclear if and how the management of these legacy patients should change in light of the current US opioid epidemic.

view more

Differential DNA Methylation Following Chemotherapy for Breast Cancer Is Associated With Lack of Memory Improvement at One Year EpigeneticsF

2019 The biological basis underlying cognitive dysfunction in women with early-stage breast cancer (BC) remains unclear, but could reflect gene expression changes that arise from the acquisition and long-term retention of soma-wide alterations in DNA methylation in response to chemotherapy. In this longitudinal study, we identified differences in peripheral methylation patterns present in women prior to treatment (T1) and 1 year after receiving chemotherapy (T4) and evaluated relationships among the differential methylation (DM) ratios with changes in cognitive function.

view more

Metabolomic Differentials in Women With and Without Fibromyalgia Clinical and Translational ScienceF

2019 A nontargeted plasma metabolomic analysis was conducted to compare differentially expressed metabolites in women with and without fibromyalgia (FM ) using data and samples collected from two parent studies in women with FM (n = 20) and comparative data collected from newly recruited age‚Äźmatched women (n = 20). Blood plasma samples were analyzed for metabolite content using liquid chromatography mass spectrometry.

view more

Relationship of fatigue with cognitive performance in women with early-stage breast cancer over 2 years. PsychooncologyF

2019 Fatigue and cognitive dysfunction are major concerns for women with early-stage breast cancer during treatment and into survivorship. However, interrelationships of these phenomena and their temporal patterns over time are not well documented, thus limiting the strategies for symptom management interventions. In this study, changes in fatigue across treatment phases and the relationship among fatigue severity and its functional impact with objective cognitive performance were examined. METHODS:Participants (N = 75) were assessed at five time points beginning prior to chemotherapy to 24 months after initial chemotherapy.

view more